Fujian Wanchen Biotechnology Co. Ltd (300972) - Total Liabilities
Based on the latest financial reports, Fujian Wanchen Biotechnology Co. Ltd (300972) has total liabilities worth CN¥5.14 Billion CNY (≈ $752.72 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Fujian Wanchen Biotechnology Co. Ltd (300972) cash flow conversion to assess how effectively this company generates cash.
Fujian Wanchen Biotechnology Co. Ltd - Total Liabilities Trend (2019–2024)
This chart illustrates how Fujian Wanchen Biotechnology Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 300972 financial resilience to evaluate the company's liquid asset resilience ratio.
Fujian Wanchen Biotechnology Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Fujian Wanchen Biotechnology Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Engie Brasil Energia S.A
F:7TE1
|
Germany | €39.90 Billion |
|
Jiangxi Copper Company Limited
F:JIX
|
Germany | €157.95 Billion |
|
SICC Co. Ltd.
SHG:688234
|
China | CN¥2.32 Billion |
|
Lear Corporation
NYSE:LEA
|
USA | $9.64 Billion |
|
Astor Enerji AS
IS:ASTOR
|
Turkey | TL17.40 Billion |
|
Beijing Enlight Media
SHE:300251
|
China | CN¥1.55 Billion |
|
Guangzhou Great Power Energy&Technology Co Ltd
SHE:300438
|
China | CN¥14.96 Billion |
|
Archrock Inc
NYSE:AROC
|
USA | $2.86 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Fujian Wanchen Biotechnology Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300972 company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.17 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fujian Wanchen Biotechnology Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fujian Wanchen Biotechnology Co. Ltd (2019–2024)
The table below shows the annual total liabilities of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥5.79 Billion ≈ $847.56 Million |
+79.35% |
| 2023-12-31 | CN¥3.23 Billion ≈ $472.58 Million |
+510.75% |
| 2022-12-31 | CN¥528.79 Million ≈ $77.38 Million |
+151.24% |
| 2021-12-31 | CN¥210.47 Million ≈ $30.80 Million |
-18.40% |
| 2020-12-31 | CN¥257.94 Million ≈ $37.74 Million |
-17.01% |
| 2019-12-31 | CN¥310.81 Million ≈ $45.48 Million |
-- |
About Fujian Wanchen Biotechnology Co. Ltd
Fujian Wanchen Food Group Co., Ltd., together with its subsidiaries, engages in the research, development, cultivation, production, and sale of edible fungi in China and internationally. The company provides enoki and golden enoki, white jade, crab, seafood, deer antler, oyster, and other mushrooms products, as well as flammulina velutipes, hydrangea edulis, and pleurotus eryngii. It is also invo… Read more